Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.36 |
| ▸ | RARA | P10276 | 2/20 | 0.36 |
| ▸ | RARG | P13631 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.34 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2478899 | 0.85 | RARB (0.39) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL18540031 | 0.84 | HTR2A (0.38) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL18540216 | 0.84 | HTR2A (0.36) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL18540229 | 0.84 | TAAR1 (0.36) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL18540147 | 0.83 | RARB (0.44) | RARBRARARARGMAPTCNR2 | |
| SCHEMBL12760546 | 0.82 | RARB (0.40) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL9999856 | 0.82 | RARB (0.40) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL16377214 | 0.82 | RARB (0.43) | RARBRARARARGTAAR1CYP17A1 | |
| SCHEMBL20803619 | 0.80 | NAAA (0.45) | CYP17A1FAAHMAPT | |
| SCHEMBL18540224 | 0.80 | MAOB (0.41) | MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1970362-B1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2011-10-12 | — | — | EP | disclosed |
| EP-1970362-B1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-7749403-B2 | Monofluorinated terphenyl compound having alkenyl, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2009-08-20 | — | — | US | disclosed |
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | JIANGSU HECHENG DISPLAY TECHNOLOGY CO., LTD. (CN) | 2009-08-20 | — | — | US | disclosed |
| EP-1970362-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
| EP-1970362-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | Chisso Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090206300-A1 | MONOFLUORINATED TERPHENYL COMPOUND HAVING ALKENYL, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, FZD7, HTR1D | RARB 3441/4885RARA 2495/4885RARG 3629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.